Bangladesh, Indonesia, Pakistan, and Serbia will also receive support from the hub in South Africa to develop messenger ribonucleic acid (mRNA) vaccines, the WHO says.
“Those countries were vetted by a group of experts and proved that they could absorb the technology and, with targeted training, move to production relatively quickly.”
The WHO hubs will serve all low- and middle-income countries wishing to produce biologicals, such as vaccines, insulin, monoclonal antibodies and cancer treatments.
“Although Việt Nam is a developing country, we have had a lot of experience in vaccine development over the past decades,” Vietnamese Minister of Health Nguyễn Thanh Long says.
”The WHO has also recognized our National Regulatory Authority. We believe that in participating in this initiative, Việt Nam will be able to produce the mRNA vaccine on a large scale, not only for domestic consumption but also for other countries in the region and the world, contributing to reducing inequalities in access to vaccines.”
In a separate development, also Indonesia could start making its own mRNA vaccines after the World Health Organization (WHO) picked it to receive a technology transfer.
State company PT Bio Farma will start producing mRNA doses, according to a statement from the State-Owned Enterprises Ministry, which did not name the brand. The company is one of the largest vaccine manufacturers in the region, with the capacity to produce 3.2 billion doses a year.
The mRNA vaccine is an advanced technology that allows fast modification and updates in response to new variants of the virus and production in large quantities.
The original articles can be found HERE and HERE.
Add Comment